Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
98.14
-4.10 (-4.01%)
Aug 20, 2026, 12:44 PM EDT - Market open

Mirum Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
330.73296.68222.5286.332831.34
Short-Term Investments
107.5686.6457.81-123.72125.2
Cash & Short-Term Investments
438.29383.33280.32286.33151.72156.54
Cash Growth
43.91%36.75%-2.10%88.72%-3.08%-32.47%
Accounts Receivable
145.36123.3378.2967.9723.993.27
Other Receivables
-----0.3
Receivables
145.36123.3378.2967.9723.993.57
Inventory
25.7724.8922.422.315.571.51
Prepaid Expenses
26.8918.1411.7810.948.954.97
Total Current Assets
636.31549.68392.79387.54190.23166.59
Property, Plant & Equipment
14.2810.69.811.992.352.55
Long-Term Investments
123.038.1112.53--4.98
Other Intangible Assets
247.39260.92249.82252.9358.9518.74
Other Long-Term Assets
23.9813.55.814.17101.38101.79
Total Assets
1,045842.81670.75646.62352.91294.65

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
23.439.6114.627.428.699.17
Accrued Expenses
107.55105.5670.9754.8934.7324.42
Current Portion of Leases
2.412.141.711.10.930.71
Other Current Liabilities
89.4188.4839.2623.6520.378.3
Total Current Liabilities
222.79205.8126.5587.0664.7342.6
Long-Term Debt
750.08309.8308.08306.42--
Long-Term Leases
10.477.527.970.621.261.9
Other Long-Term Liabilities
72.075.012.513.85144.88129.94
Total Liabilities
1,055528.12445.11397.95210.87174.44

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.0100
Additional Paid-In Capital
1,515981.88870.19803.26535.07377.4
Retained Earnings
-1,525-667.54-644.18-556.24-392.82-257.16
Comprehensive Income & Other
-0.670.35-0.371.64-0.22-0.04
Total Common Equity
-10.42314.69225.64248.67142.04120.21
Shareholders' Equity
-10.42314.69225.64248.67142.04120.21
Total Liabilities & Equity
1,045842.81670.75646.62352.91294.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
762.95319.45317.76308.142.192.61
Net Cash (Debt)
-324.6663.88-37.45-21.82149.53153.93
Net Cash Growth
-----2.86%-32.65%
Net Cash Per Share
-5.791.27-0.79-0.534.405.08
Filing Date Shares Outstanding
64.9360.3449.014737.9531.73
Total Common Shares Outstanding
64.7551.948.3446.7236.9630.58
Working Capital
413.52343.89266.24300.48125.5124
Book Value Per Share
-0.166.064.675.323.843.93
Tangible Book Value
-257.8153.77-24.18-4.2683.08101.47
Tangible Book Value Per Share
-3.981.04-0.50-0.092.253.32
Machinery
-2.161.640.910.60.2
Leasehold Improvements
-0.80.21.31.311.48
SEC Filings: 10-K · 10-Q